---
$id: https://graph.org.ai/products/commodity/51161551
$type: Product
source: UNSPSC
code: "51161551"
title: "Perbufylline"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Perbufylline

**UNSPSC Code**: 51161551
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor and bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M69H5TDQ1K. European Medicines Agency schedules Perbufylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09717MIG. Perbufylline generally arises in the molecular formula C23H28FN5O3. The term PERBUFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, no. 3, 1988, list 28.) PERBUFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule perbufylline under HS 29395900 and SITC 54145. As of Q4 2014, PERBUFYLLINE remains the US FDA Preferred Term for this commodity. Perbufylline bears US NLM identifiers UMLS ID C1882325 and NCI Concept Code C66354. SMILES: FC1CCC(C(=O)C2CCN(CC2)CCCCN2C3C(N(C(=O)N(C3=O)C)C)NC2)CC1.

